Harada Toxoplasmosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization (NCT00645697) | Rafic Hariri University Hospital | 2007-01-01 |
Track Harada Toxoplasmosis automatically
Every clearance here is in the API, with alerts when new ones post.